Join Our FREE Live Webinar!
Exploring Biomolecules: Oligonucleotide Basics Unleashed!
Namrata Saxena
Technical Manager, Phenomenex
Tuesday, April 8, 2025
10:00 AM (PT)
Overview
Oligonucleotide therapeutics are a widely accepted form of therapy because of their ability to treat diseases at the genetic level. Current advances in oligonucleotide therapeutic research push the boundaries of analytics to ensure safety and efficacy.
Key Learning Points
- Learn about the basic building blocks and structures of oligonucleotides
- Understand oligonucleotide modifications and how they impact the chemical and physical properties
- Explore how oligonucleotides function as a biotherapeutic
- Expand knowledge of analyzing oligonucleotides and address current analytical challenges
Who Should Attend
- This webinar is tailored for scientists, researchers, and industry professionals working in oligonucleotide development, manufacturing, and analytical testing that wish to learn more about oligonucleotides and its applications.
Speaker Bio
Namrata is the Technical Manager for the Asia-Pacific region in Phenomenex and is based in Australia. As a member of the global technical team, she is responsible for assisting customers and the internal marketing and sales teams of Phenomenex for multifarious technical queries. She also support company’s bio-products portfolio through external and internal seminars/webinars, training, and technical content creation. Her competence and focus lie in providing chromatographic solutions for characterization workflows of biotherapeutics and new and emerging CGT modalities.
Before joining Phenomenex she had worked as a Product Specialist and spent several years in stationary phase chemistry, column manufacturing and method development groups in a German company Bischoff Chromatography GmbH.
Namrata has a post graduate degree with specialization in Analytical Chemistry.
By submitting your information, you agree that Phenomenex may collect and further process your personal data in accordance with its Privacy Policy.
You may object to receiving further information at any time.
